LMAT has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
LMAT has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2024-04-17), LeMaitre Vascular's share price is $63.04. LeMaitre Vascular's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.64. Hence, LeMaitre Vascular's Price-to-Operating-Cash-Flow Ratio for today is 38.53.
The historical rank and industry rank for LeMaitre Vascular's Price-to-Operating-Cash-Flow or its related term are showing as below:
During the past 13 years, LeMaitre Vascular's highest Price-to-Operating-Cash-Flow Ratio was 66.03. The lowest was 17.77. And the median was 29.48.
LeMaitre Vascular's Cash Flow from Operations per share for the three months ended in Dec. 2023 was $0.48. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $1.64.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of LeMaitre Vascular was 43.10% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -1.20% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 12.40% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 16.30% per year.
During the past 13 years, LeMaitre Vascular's highest 3-Year average Operating Cash Flow per Share Growth Rate was 74.90% per year. The lowest was -7.90% per year. And the median was 17.80% per year.
The historical data trend for LeMaitre Vascular's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, LeMaitre Vascular's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Medical Devices & Instruments industry and Healthcare sector, LeMaitre Vascular's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where LeMaitre Vascular's Price-to-Operating-Cash-Flow falls into.
LeMaitre Vascular's Price-to-Operating-Cash-Flow ratio for today is calculated as
Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
= | 63.04 | / | 1.636 | |
= | 38.53 |
LeMaitre Vascular's Share Price of today is $63.04.
LeMaitre Vascular's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.64.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Price-to-Operating-Cash-Flow Ratio | = | Market Cap | / | Cash Flow from Operations |
Thank you for viewing the detailed overview of LeMaitre Vascular's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
George W Lemaitre | director, 10 percent owner, officer: Chairman, President and CEO | 342 BUNKER HILL STREET, #2B, CHARLESTOWN MA 02129 |
Bridget A Ross | director | C/O HENRY SCHEIN, INC., 135 DURYEA ROAD, MELVILLE NY 11747 |
John A Roush | director | C/O GSI GROUP INC., 125 MIDDLESEX TURNPIKE, BEDFORD MA 01730-1409 |
Lawrence J Jasinski | director | SOTEIRA INC., 14 TECH CIRCLE, NATICK MA 01760 |
David B Roberts | director, officer: CFO and Director | 55 BRADFORD STREET, NEEDHAM MA 02492 |
Trent G Kamke | officer: Senior V. P., Operations | 61 WILLOWDEAN AVENUE, WEST ROXBURY MA 02132 |
Martha Shadan | director | 9201 W BROADWAY AVE, #650, MINNEAPOLIS MN 55445 |
Pellegrino Joseph P Jr | officer: Executive V.P. Finance | 68 BEACON STREET, BOSTON MA 02108 |
Michael H Thomas | director | P.O. BOX 2207, NOKOMIS FL 34274-2207 |
Peter R Gebauer | officer: President, International OP | AM WALDFELD 17, BAD SODEN 2M 65812 |
Michael T Wijas | officer: VP of Sales, The Americas | C/O LEMAITRE VASCULAR, INC., 63 SECOND AVENUE, BURLINGTON MA 01803 |
Lemaitre Cornelia W | director, officer: V.P., Human Resources,Director | 8 SUNSET ROCK ROAD, ANDOVER MA 01810 |
Russell D Hays | director | C/O BIOSOURCE INTERNATIONAL INC, 542 FLYNN RD, CAMARILLO CA 93012 |
Robert V Linden | officer: VP, North American Sales | 236 WOODEN BRIDGE ROAD, HOLLAND PA 18966 |
Thorndike William N Jr | director | HOUSATONIC PARTNERS, 800 BOYLSTON STREET, SUITE 2220, BOSTON MA 02199 |
From GuruFocus
By GuruFocus Research • 11-01-2023
By GlobeNewswire GlobeNewswire • 06-06-2023
By GlobeNewswire GlobeNewswire • 10-17-2022
By GlobeNewswire • 07-17-2023
By GuruFocus Research • 08-02-2023
By GlobeNewswire GlobeNewswire • 07-18-2022
By GuruFocus Research GuruFocus Editor • 05-19-2023
By Value_Insider Value_Insider • 10-17-2022
By Marketwired • 08-01-2023
By PurpleRose PurpleRose • 08-01-2022
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.